o-Toluoyl Chloride CAS 933-88-0 Tolvaptan Intermediate Factory High Quality
Ukunikezwa Komkhiqizi, Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo
I-Tolvaptan kanye Nezixhumanisi Ezihlobene:
I-Tolvaptan CAS 150683-30-0
7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one CAS 160129-45-3
o-Toluoyl Chloride CAS 933-88-0
I-4-Amino-2-Methylbenzoic Acid CAS 2486-75-1
I-2-Methyl-4-Nitrobenzoic Acid CAS 1975-51-5
Igama Lekhemikhali | o-Toluoyl Chloride |
Omqondofana | 2-Methylbenzoyl Chloride |
Inombolo ye-CAS | 933-88-0 |
Inombolo yeCAT | I-RF-PI396 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
I-Molecular Formula | C8H7ClO |
Isisindo samangqamuzana | 154.59 |
I-Melting Point | 159.5-160.9℃ |
Iphuzu elibilayo | 88.0~90.0℃/12 mmHg (lit.) |
Ukuminyana | 1.185 g/mL ku-25℃ (lit.) |
I-Refractive Index | n20/D 1.5549(lit.) |
Ukuncibilika kwamanzi | Isabela naManzi |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Uketshezi Olucacile Olungenambala |
Isivivinyo | ≥99.0% |
I-benzoyl chloride | ≤0.30% |
I-M&P-Methyl Benzoyl Chloride | ≤0.50% |
I-O-Toluic Acid | ≤0.50% |
Okunye Ukungcola Okungacacisiwe | ≤0.20% |
Ukungcola Okuphelele | ≤1.0% |
Ukulahlekelwa Ekumisweni | ≤0.50% |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | Pharmaceutical Intermediates |
Iphakheji: Ibhodlela, 25kg/Umgqomo noma 180kg Isigubhu sePlastiki, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama.
I-o-Toluoyl Chloride (CAS 933-88-0) isetshenziswa njengendawo emaphakathi yemithi.I-o-Toluoyl Chloride isetshenziswa ekuhlanganiseni uma i-quinolinone ihlanganiswa njenge-SARS CoV 3CLpro inhibitors.Ibuye isetshenziswe ekuhlanganisweni kwe-benzooxaboroles njengama-ejenti aphikisana nokuvuvukala ngomlomo.I-o-Toluoyl Chloride iphakathi kwe-Tolvaptan (CAS 150683-30-0) yokwelashwa kwe-hyponatremia.I-Tolvaptan, eyaziwa nangokuthi i-OPC-41061, i-arginine vasopressin receptor 2 antagonist ekhethiwe, encintisanayo esetshenziselwa ukwelapha i-hyponatremia (amazinga aphansi e-sodium yegazi) ehambisana nokuhluleka kwenhliziyo, i-cirrhosis, kanye nesifo se-antidiuretic hormone engafaneleki (SIADH).I-Otsuka Pharmaceutical inelayisensi ye-tolvaptan ngaphansi kwegama lokuhweba i-Samsca ngemuva kokuthi i-FDA iphasise umuthi ngoMeyi 2009.